Daniel D Burgess - Net Worth and Insider Trading
Daniel D Burgess Net Worth
The estimated net worth of Daniel D Burgess is at least $2,010 dollars as of 2024-11-13. Daniel D Burgess is the Director of Cidara Therapeutics Inc and owns about 150 shares of Cidara Therapeutics Inc (CDTX) stock worth over $2,009. Daniel D Burgess is also the Director of Nabriva Therapeutics PLC and owns about 415 shares of Nabriva Therapeutics PLC (NBRVF) stock worth over $0. Details can be seen in Daniel D Burgess's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel D Burgess has not made any transactions after 2022-08-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Daniel D Burgess
Daniel D Burgess Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel D Burgess owns 5 companies in total, including Nabriva Therapeutics PLC (NBRVF) , Cidara Therapeutics Inc (CDTX) , and Arbutus Biopharma Corp (ABUS) among others .
Click here to see the complete history of Daniel D Burgess’s form 4 insider trades.
Insider Ownership Summary of Daniel D Burgess
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NBRVF | Nabriva Therapeutics PLC | 2022-08-02 | director |
| CDTX | Cidara Therapeutics Inc | 2020-06-25 | director |
| ABUS | Arbutus Biopharma Corp | 2017-03-23 | director |
 | | 2009-06-23 | director |
| | 2004-01-16 | COO/CFO |
Daniel D Burgess Latest Holdings Summary
Daniel D Burgess currently owns a total of 2 stocks. Among these stocks, Daniel D Burgess owns 150 shares of Cidara Therapeutics Inc (CDTX) as of April 20, 2015, with a value of $2,009 and a weighting of 100%. Daniel D Burgess also owns 415 shares of Nabriva Therapeutics PLC (NBRVF) as of August 2, 2022, with a value of $0 and a weighting of 0%.
Latest Holdings of Daniel D Burgess
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CDTX | Cidara Therapeutics Inc | 2015-04-20 | 150 | 13.40 | 2,009 |
| NBRVF | Nabriva Therapeutics PLC | 2022-08-02 | 415 | 0.00 | 0 |
Holding Weightings of Daniel D Burgess
Daniel D Burgess Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel D Burgess has made a total of 0 transactions in Cidara Therapeutics Inc (CDTX) over the past 5 years. The most-recent trade in Cidara Therapeutics Inc is the acquisition of 150 shares on April 20, 2015, which cost Daniel D Burgess around $48,000.
According to the SEC Form 4 filings, Daniel D Burgess has made a total of 2 transactions in Nabriva Therapeutics PLC (NBRVF) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Nabriva Therapeutics PLC is the sale of 454 shares on August 2, 2022, which brought Daniel D Burgess around $2,155.
Insider Trading History of Daniel D Burgess
- 1
Daniel D Burgess Trading Performance
GuruFocus tracks the stock performance after each of Daniel D Burgess's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel D Burgess is -14.62%. GuruFocus also compares Daniel D Burgess's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel D Burgess within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Daniel D Burgess's insider trading performs compared to the benchmark.
Performance of Daniel D Burgess
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.33 | | | | | |
| Relative Return to S&P 500(%) | -1.79 | | | | | |
Daniel D Burgess Ownership Network
Ownership Network List of Daniel D Burgess
Ownership Network Relation of Daniel D Burgess
Daniel D Burgess Owned Company Details
What does Nabriva Therapeutics PLC do?
Who are the key executives at Nabriva Therapeutics PLC?
Daniel D Burgess is the director of Nabriva Therapeutics PLC. Other key executives at Nabriva Therapeutics PLC include Chief Executive Officer Hogan H Michael Iii , Chief Financial Officer David Maggio , and Chief Executive Officer Broom Colin Md .
Nabriva Therapeutics PLC (NBRVF) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Nabriva Therapeutics PLC (NBRVF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nabriva Therapeutics PLC (NBRVF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Nabriva Therapeutics PLC (NBRVF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nabriva Therapeutics PLC Insider Transactions
Daniel D Burgess Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel D Burgess. You might contact Daniel D Burgess via mailing address: C/o Hollis-eden Pharmaceuticals, 4435 Eastgate Mall Ste.400, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
